Added Value of SVC Isolation in Patients With Pulmonary Vein Reconnection Undergoing Repeat Ablation for Recurrent Paroxysmal AF
NCT04602169 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108
Last updated 2022-08-03
Summary
Redo procedures after CLOSE-guided pulmonary vein isolation (PVI) for atrial fibrillation (AF) occur in 10% of patients. In case of pulmonary vein (PV) reconnection, electrophysiologists may re-isolate the pulmonary veins with or without the ablation of other commonly known PV-triggers. The superior vena cava (SVC) is one of the most common non PV-triggers for atrial tachyarrhythmias. SVC electrical isolation can be reached by circular radiofrequency-ablation under close monitoring of the phrenic nerve. However, it's added value remains unclear.
With this prospective, randomized, controlled, unblinded, mono-center study, the investigators aim to evaluate the 1-year recurrence rate in paroxysmal AF patients with reconnected pulmonary veins during a redo ablation with PV re-isolation or PV re-isolation with SVC isolation.
Conditions
- Paroxysmal Atrial Fibrillation
Interventions
- PROCEDURE
-
PVI
PV re-isolation will be conducted according to the CLOSE-protocol. Point-by-point radiofrequency (RF) delivery will be performed aiming for a contiguous circle enclosing all PVs. RF will be delivered in a power-controlled mode (without ramping) using 35-40 Watt. The irrigation rate will be set at 30 ml/min. RF will be delivered until an ablation index (AI) of ≥400 is reached at the posterior wall and ≥550 at the anterior wall. In case of dislocation, a new RF application reaching the AI target will be applied. Maximal intertag distance between two neighboring lesions is 6 mm. In case of intra-esophageal temperature (T°) rise \>38.5°C during posterior LA wall ablation, RF delivery will stopped at an AI of 300. In the absence of first pass isolation, touch-up ablation was applied until PVI. In case of reconnection during the waiting time or during the adenosine test, the site of reconnection will be located and treated with touch-up ablation until adenosine proof PVI is reached.
- PROCEDURE
-
PVI + SVC
Patients in this group receive PVI according to the CLOSE protocol. In addition, they will receive an SVC isolation. The circular mapping catheter will be introduced in the superior vena cava to determine baseline electrical activity and to confirm definite entrance and exit block after ablation. Ablation will be performed proximally to the SVC/right atrial junction with the contact force-catheter using circular point-by-point radiofrequency delivery with a power setting of 35W, targeting an AI ≥400. High output (25 mA) pacing will be applied before each RF application to check for phrenic nerve stimulation. In areas of phrenic nerve capture ablation will be avoided even in case of incomplete isolation.
Sponsors & Collaborators
-
AZ Sint-Jan AV
lead OTHER
Principal Investigators
-
Sébastien Knecht, MD, PhD · AZ Sint-Jan AV
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-11-16
- Primary Completion
- 2023-09-30
- Completion
- 2023-09-30
Countries
- Belgium
Study Locations
More Related Trials
-
Clinical Impact of Autonomic Modulation After Pulmonary Vein Isolation
NCT02733913 ·Status: COMPLETED
-
Outcome of Atrial Fibrillation Ablation After Permanent Pulmonary Vein Antrum Isolation With or Without Proven Left Atrial Posterior Wall Isolation
NCT01660100 ·Status: COMPLETED ·Phase: NA
-
Cryoballoon Isolation of Superior Vena Cava in Paroxysmal Atrial Fibrillation
NCT05081310 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy of Pulmonary Vein Isolation Alone in Patients With Persistent Atrial Fibrillation
NCT03514693 ·Status: UNKNOWN ·Phase: NA
-
Surgical Pulmonary Vein Isolation Efficiency Study
NCT01791218 ·Status: TERMINATED ·Phase: NA
-
Very High Power Ablation in Patients With Atrial Fibrillation Scheduled for a First Pulmonary Vein Isolation
NCT04784013 ·Status: COMPLETED ·Phase: PHASE4
-
Pulsed Field Ablation Versus Conventional Radiofrequency Catheter Ablation for Repeat PVI in Patients With Paroxysmal AF
NCT06199180 ·Status: RECRUITING ·Phase: NA
-
Left Atrial Function Analysis for Patients With Persistent Atrial Fibrillation Undergoing Pulmonary Vein Isolation
NCT03242694 ·Status: UNKNOWN
-
Swiss Atrial Fibrillation Pulmonary Vein Isolation Registry
NCT03718364 ·Status: RECRUITING
-
Video-Assisted Thoracoscopic Pulmonary Vein Isolation Versus Percutaneous Catheter Ablation in Atrial Fibrillation Trial
NCT01319747 ·Status: TERMINATED ·Phase: NA
-
Pulmonary Vein Antrum Isolation (PVAI) Plus Scar Homogenization and Non-PV Triggers Ensure Long-term Recurrence-free Survival in Non-paroxysmal Atrial Fibrillation
NCT01672138 ·Status: UNKNOWN ·Phase: NA
-
Esophageal Safety of High and Very High Power Short Duration Pulmonary Vein Isolation: a Randomized Comparison of the 50W and 90W Power Settings
NCT06617442 ·Status: COMPLETED ·Phase: NA
-
Pulmonary Vein (PV) Isolation Versus Box Isolation for the Treatment of Atrial Fibrillation
NCT01091597 ·Status: COMPLETED ·Phase: NA
-
Comparison of Redo PVI With vs. Without Renal Denervation for Recurrent AF After Initial PVI
NCT01959997 ·Status: UNKNOWN ·Phase: PHASE2
-
Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation
NCT04702451 ·Status: COMPLETED ·Phase: NA
-
Quantitative Superior Vena Cava Isolation in Addition to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation
NCT05908955 ·Status: RECRUITING ·Phase: NA
-
Contact Force Guided Ablation Versus Conventional Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation
NCT02816268 ·Status: COMPLETED ·Phase: NA
-
Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment in Subjects With Recurrent Atrial Fibrillation
NCT02475642 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Feasibility of Electrical Isolation of the Superior Vena Cava for Paroxysmal Atrial Fibrillation
NCT03190096 ·Status: UNKNOWN
-
Single Versus Double Cryoballoon Ablation for Pulmonary Vein Isolation in Patients With Atrial Fibrillation
NCT03003975 ·Status: COMPLETED ·Phase: NA
-
Pulsed Field or Cryoballoon Pulmonary Vein Isolation for Atrial Fibrillation in Heart Failure
NCT07181291 ·Status: COMPLETED
-
Contact Force Sensing and Pulmonary Vein Isolation
NCT01630031 ·Status: UNKNOWN
-
Incidence and Duration of Unintentional Neuromodulation Effects After Pulmonary Vein Isolation in Patients With Atrial Fibrillation.
NCT05677516 ·Status: UNKNOWN
-
Pulmonary Vein Isolation Versus Botulinum Toxin Injection Plus Pulmonary Vein Isolation in Patients With Atrial Fibrillation
NCT02002923 ·Status: UNKNOWN ·Phase: PHASE2
-
Cavotricuspid Isthmusblock and Circumferential Pulmonary Vein Isolation in Patients With Atrial Fibrillation
NCT00247780 ·Status: COMPLETED ·Phase: PHASE4